From Alchemy to IPO
About
It is impossible to dispute the extraordinary impact biotechnology is having on our everyday lives. Companies such as Genentech, Immunex, Amgen and Biogen hold the technological and intellectual keys to controlling our genetic destiny and moving science to a new apex of breakthrough cures. Written by a well-known industry insider, this title addresses the coming-of-age of biotech products and companies and traces the history of biotechnology from its early inception in the ʼ70s to todayʼs heyday of new solutions and breakthrough treatments.
Discuss From Alchemy to IPO with other readers
Join or start a book club for From Alchemy to IPO on Readfeed. Live chat, shared reading progress, and AI discussion questions — free to get started.
Frequently asked questions
How do I join a book club for From Alchemy to IPO?
Sign up free on Readfeed, then browse public clubs or start your own club with From Alchemy to IPO as the current read. Invite friends with a share link and discuss together with live chat and AI discussion questions.
Can I discuss From Alchemy to IPO with other readers online?
Yes. Readfeed book clubs let you chat live, share progress, and join discussions about From Alchemy to IPO with readers worldwide — whether your club is virtual, in-person, or hybrid.
Is Readfeed free?
Yes. Creating an account and joining book clubs is free. Sign up to find readers who love the same books and start discussing today.